|
|
Blood, 15 November 2004, Vol. 104, No. 10, pp. 3294-3301.
Prepublished online as a Blood First Edition Paper on July 22, 2004; DOI 10.1182/blood-2004-03-1214.
Previous Article | Next Article 
Submitted April 1, 2004
Accepted June 29, 2004
Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation
Emmanuel Xystrakis, Anne S Dejean, Isabelle Bernard, Philippe Druet, Roland Liblau, Daniel Gonzalez-Dunia, and Abdelhadi Saoudi*
CPTP, INSERM Unite 563 and IFR30, Toulouse, France
* Corresponding author; email: Abdelhadi.Saoudi{at}toulouse.inserm.fr.
The immune system contains natural regulatory T cells that control the magnitude of the immune response during physiological and pathological conditions. Although this suppressive function was historically attributed to CD8 T cells, most recent reports have focused on natural regulatory CD4 T cells. In the present study, we describe a new subset of natural CD8 regulatory T cells in normal healthy animals. This subset expresses low levels of CD45RC at its surface (CD45RClow), produces mainly IL-4, IL-10 and IL-13 cytokines upon in vitro stimulation, expresses Foxp3 and CTLA-4, and is not cytotoxic against allogeneic targets. This subset suppresses the proliferation and differentiation of autologous CD4 T cells into type-1 cytokines producing T cells after stimulation with allogeneic accessory cells. We also provide evidence that this regulatory subset mediates its suppression by cell-to-cell contact and not through secretion of suppressive cytokines. Finally, the regulatory activity of CD8 CD45RClow cells is also demonstrated in vivo in a rat model of CD4-dependent Graft-versus Host Disease. Collectively, these data demonstrate for the first time that freshly isolated rat CD8 CD45RClow T cells contain T cells with regulatory properties, a result that enlarges the general figure of T cell mediated regulation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. E. Cone, S. Chattopadhyay, R. Sharafieh, Y. Lemire, J. O'Rourke, R. A. Flavell, and R. B. Clark
T cell sensitivity to TGF-{beta} is required for the effector function but not the generation of splenic CD8+ regulatory T cells induced via the injection of antigen into the anterior chamber
Int. Immunol.,
May 1, 2009;
21(5):
567 - 574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N Chaput, S Louafi, A Bardier, F Charlotte, J-C Vaillant, F Menegaux, M Rosenzwajg, F Lemoine, D Klatzmann, and J Taieb
Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue
Gut,
April 1, 2009;
58(4):
520 - 529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Suberbielle, A. Stella, F. Pont, C. Monnet, E. Mouton, L. Lamouroux, B. Monsarrat, and D. Gonzalez-Dunia
Proteomic Analysis Reveals Selective Impediment of Neuronal Remodeling upon Borna Disease Virus Infection
J. Virol.,
December 15, 2008;
82(24):
12265 - 12279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Fudaba, T. Onoe, M. Chittenden, A. Shimizu, J. M. Shaffer, R. Bronson, and M. Sykes
Abnormal Regulatory and Effector T Cell Function Predispose to Autoimmunity following Xenogeneic Thymic Transplantation
J. Immunol.,
December 1, 2008;
181(11):
7649 - 7659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rifa'i, Z. Shi, S.-Y. Zhang, Y. H. Lee, H. Shiku, K.-i. Isobe, and H. Suzuki
CD8+CD122+ regulatory T cells recognize activated T cells via conventional MHC class I-{alpha}{beta}TCR interaction and become IL-10-producing active regulatory cells
Int. Immunol.,
July 1, 2008;
20(7):
937 - 947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Nam, M. Terabe, M.-J. Kang, H. Chae, N. Voong, Y.-a. Yang, A. Laurence, A. Michalowska, M. Mamura, S. Lonning, et al.
Transforming Growth Factor {beta} Subverts the Immune System into Directly Promoting Tumor Growth through Interleukin-17
Cancer Res.,
May 15, 2008;
68(10):
3915 - 3923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ishimaru, A. Yamada, M. Kohashi, R. Arakaki, T. Takahashi, K. Izumi, and Y. Hayashi
Development of Inflammatory Bowel Disease in Long-Evans Cinnamon Rats Based on CD4+CD25+Foxp3+ Regulatory T Cell Dysfunction
J. Immunol.,
May 15, 2008;
180(10):
6997 - 7008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Ruzek, J. S. Waire, D. Hopkins, G. LaCorcia, J. Sullivan, B. L. Roberts, S. M. Richards, S. R. Nahill, J. M. Williams, A. Scaria, et al.
Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivo
Blood,
February 1, 2008;
111(3):
1726 - 1734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Billerbeck, H. E. Blum, and R. Thimme
Parallel Expansion of Human Virus-Specific FoxP3- Effector Memory and De Novo-Generated FoxP3+ Regulatory CD8+ T Cells upon Antigen Recognition In Vitro
J. Immunol.,
July 15, 2007;
179(2):
1039 - 1048.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Prevosto, M. Zancolli, P. Canevali, M. R. Zocchi, and A. Poggi
Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction
Haematologica,
July 1, 2007;
92(7):
881 - 888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Singh, A. La Cava, M. Wong, F. Ebling, and B. H. Hahn
CD8+ T Cell-Mediated Suppression of Autoimmunity in a Murine Lupus Model of Peptide-Induced Immune Tolerance Depends on Foxp3 Expression
J. Immunol.,
June 15, 2007;
178(12):
7649 - 7657.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. P. A. MacDonald, R. D. Kuns, V. Rowe, E. S. Morris, T. Banovic, H. Bofinger, B. O'Sullivan, K. A. Markey, A. L. Don, R. Thomas, et al.
Effector and regulatory T-cell function is differentially regulated by RelB within antigen-presenting cells during GVHD
Blood,
June 1, 2007;
109(11):
5049 - 5057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Peng, H. Shao, Y. Ke, P. Zhang, G. Han, H. J. Kaplan, and D. Sun
Minimally Activated CD8 Autoreactive T Cells Specific for IRBP Express a High Level of Foxp3 and Are Functionally Suppressive
Invest. Ophthalmol. Vis. Sci.,
May 1, 2007;
48(5):
2178 - 2184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Wahl, P. Bochtler, R. Schirmbeck, and J. Reimann
Type I IFN-Producing CD4 V{alpha}14i NKT Cells Facilitate Priming of IL-10-Producing CD8 T Cells by Hepatocytes
J. Immunol.,
February 15, 2007;
178(4):
2083 - 2093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Callaghan, F. J. Rouhani, M. C. Negus, A. J. Curry, E. M. Bolton, J. A. Bradley, and G. J. Pettigrew
Abrogation of Antibody-Mediated Allograft Rejection by Regulatory CD4 T Cells with Indirect Allospecificity
J. Immunol.,
February 15, 2007;
178(4):
2221 - 2228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Tang, I. Maricic, N. Purohit, B. Bakamjian, L. M. Reed-Loisel, T. Beeston, P. Jensen, and V. Kumar
Regulation of Immunity by a Novel Population of Qa-1-Restricted CD8{alpha}{alpha}+TCR{alpha}beta+ T Cells
J. Immunol.,
December 1, 2006;
177(11):
7645 - 7655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-L. Hillebrands, B. Whalen, J. T. J. Visser, J. Koning, K. D. Bishop, J. Leif, J. Rozing, J. P. Mordes, D. L. Greiner, and A. A. Rossini
A Regulatory CD4+ T Cell Subset in the BB Rat Model of Autoimmune Diabetes Expresses Neither CD25 Nor Foxp3
J. Immunol.,
December 1, 2006;
177(11):
7820 - 7832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Kapp, K. Honjo, L. M. Kapp, X. y. Xu, A. Cozier, and R. P. Bucy
TCR transgenic CD8+ T cells activated in the presence of TGF{beta} express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection
Int. Immunol.,
November 1, 2006;
18(11):
1549 - 1562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Reibke, N. Garbi, R. Ganss, G. J. Hammerling, B. Arnold, and T. Oelert
CD8+ regulatory T cells generated by neonatal recognition of peripheral self-antigen
PNAS,
October 10, 2006;
103(41):
15142 - 15147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Noble, A. Giorgini, and J. A. Leggat
Cytokine-induced IL-10-secreting CD8 T cells represent a phenotypically distinct suppressor T-cell lineage
Blood,
June 1, 2006;
107(11):
4475 - 4483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Gonzalez-Rey, A. Chorny, A. Fernandez-Martin, D. Ganea, and M. Delgado
Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells
Blood,
May 1, 2006;
107(9):
3632 - 3638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Zheng, L. Meng, J. H. Wang, M. Watanabe, M. L. Barr, D. V. Cramer, J. D. Gray, and D. A. Horwitz
Transfer of regulatory T cells generated ex vivo modifies graft rejection through induction of tolerogenic CD4+CD25+ cells in the recipient
Int. Immunol.,
February 1, 2006;
18(2):
279 - 289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Duplan, G. Beriou, J.-M. Heslan, C. Bruand, P. Dutartre, L. T. Mars, R. S. Liblau, M.-C. Cuturi, and A. Saoudi
LF 15-0195 Treatment Protects against Central Nervous System Autoimmunity by Favoring the Development of Foxp3-Expressing Regulatory CD4 T Cells
J. Immunol.,
January 15, 2006;
176(2):
839 - 847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. H. Hahn, R. P. Singh, A. La Cava, and F. M. Ebling
Tolerogenic Treatment of Lupus Mice with Consensus Peptide Induces Foxp3-Expressing, Apoptosis-Resistant, TGF{beta}-Secreting CD8+ T Cell Suppressors
J. Immunol.,
December 1, 2005;
175(11):
7728 - 7737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Dercamp, K. Chemin, C. Caux, G. Trinchieri, and A. P. Vicari
Distinct and Overlapping Roles of Interleukin-10 and CD25+ Regulatory T Cells in the Inhibition of Antitumor CD8 T-Cell Responses
Cancer Res.,
September 15, 2005;
65(18):
8479 - 8486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Poussier, T. Ning, T. Murphy, D. Dabrowski, and S. Ramanathan
Impaired Post-Thymic Development of Regulatory CD4+25+ T Cells Contributes to Diabetes Pathogenesis in BB Rats
J. Immunol.,
April 1, 2005;
174(7):
4081 - 4089.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|